Description: Myeloproliferative Neoplasms (MPNs) are a type of cancers in the blood that cause a surplus of white or red blood cells, or platelets, which leads to issues
polycythemia vera (3) primary myelofibrosis (2) myelofibrosis neoplasms (1) jak2 mutation (1) myeloproliferative neoplasms (1) myeloproliferative disorders (1)
Myeloproliferative Neoplasms (MPNs) are a type of cancers in the blood that cause a surplus of white or red blood cells, or platelets, which leads to issues with blood flow. The three types of MPNs include Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis.
According to the Leukemia & Lymphoma Society, Myelofibrosis develops when the bone marrow produces a surplus of blood cells and scar tissue begins to form in the bone marrow. Myelofibrosis can affect anyone, but it is most common for people over the age of 50 and it only affects 1.5 out of every 100,000 people in the U.S. annually.
Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome.